![Margaret Cabano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Margaret Cabano
Directeur des opérations chez NEOS THERAPEUTICS, INC.
Postes actifs de Margaret Cabano
Sociétés | Poste | Début | Fin |
---|---|---|---|
NEOS THERAPEUTICS, INC. | Directeur des opérations | 01/01/2005 | - |
AYTU BIOPHARMA, INC. | Directeur des opérations | 01/01/2005 | - |
Historique de carrière de Margaret Cabano
Anciens postes connus de Margaret Cabano
Sociétés | Poste | Début | Fin |
---|---|---|---|
CARDINAL HEALTH, INC. | Corporate Officer/Principal | - | - |
Adams Respiratory Therapeutics, Inc.
![]() Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Corporate Officer/Principal | - | - |
Formation de Margaret Cabano
University of North Texas | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Chief Operating Officer | 2 |
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
AYTU BIOPHARMA, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Neos Therapeutics, Inc.
![]() Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Adams Respiratory Therapeutics, Inc.
![]() Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Health Technology |
- Bourse
- Insiders
- Margaret Cabano
- Expérience